Lundbeck Seizure Drug Poses Serious Skin Risks, FDA Warns
Drugmaker Lundbeck Inc.'s seizure medication Onfi may cause rare but potentially fatal skin reactions including toxic epidermal necrolysis, a condition characterized by the peeling away of skin cells, the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article